{
  "ptid_time": "023_S_0139_2008-03-04",
  "img_path": "/data/qiuhui/data/adni/images/023_S_0139/2008-03-04/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 37,229 mm³, 66.7% above the reference mean. With a Z-score of 1.67 (95.2th percentile), this represents moderate enlargement; hippocampal volume measures 4,550 mm³, 40.8% below the reference mean. With a Z-score of -4.58 (0.0th percentile), this represents profound atrophy; whole brain volume measures 815,557 mm³, 20.8% below the reference mean. With a Z-score of -2.58 (0.5th percentile), this represents significant atrophy; entorhinal cortex volume measures 3,072 mm³, 21.1% below the reference mean. With a Z-score of -1.63 (5.1th percentile), this represents moderate atrophy; fusiform gyrus volume measures 14,716 mm³, 19.2% below the reference mean. With a Z-score of -2.16 (1.5th percentile), this represents significant atrophy; middle temporal gyrus volume measures 12,495 mm³, 39.1% below the reference mean. With a Z-score of -3.48 (0.0th percentile), this represents profound atrophy. ",
  "text_data": "Age is 67.9 years. Gender is Female. Education: 13 years. MMSE: 22.0. Logical Memory: 0.0. Laboratory findings: MCHC: 30.00 (significant reduced). APOEε4 alleles: 2.0. Biomarker levels: Amyloid beta: 456.20 pg/mL (mild reduced); Total tau: 340.40 pg/mL (mild elevated); Phosphorylated tau: 35.63 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows profound hippocampal and middle temporal gyrus atrophy, significant whole brain and fusiform gyrus atrophy, and moderate entorhinal cortex atrophy, alongside ventricular enlargement—all consistent with Alzheimer’s neurodegeneration. The clinical profile (MMSE 22, APOE4 homozygous, Aβ reduction, and elevated tau) further supports AD pathology.  \n\n**Diagnosis:** Dementia (likely Alzheimer’s disease)  \n**Confidence:** High",
  "timestamp": "2025-07-26T02:38:26.969724"
}